Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2035

Annual patent cliff calendar for 2035 — US pharmaceutical patents by expiration date.

Patents
1,447

Quick answer

1,447 indexed pharmaceutical patents have expiration dates in 2035. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9023795

    Angiogenesis-inhibiting peptide and application thereof

    SHANGHAI FIRST PEOPLE'S HOSPITAL · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 9024069

    NONOate derivatives and uses thereof

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 9023798

    Cystinosin replacement factor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 9023984

    Diagnostic and therapeutic target for autoimmune diseases and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 9023322

    Chewing gum compositions comprising cannabinoids

    Stichting Sanammad · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 9023340

    Wnt inhibitors for human stem cell differentiation

    ChemRegen, Inc. · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9023866

    2-selenophene-4-quinolones as anticancer agents

    China Medical University · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 9023867

    Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents

    China Medical University · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 9023823

    Micro-RNA's that regulate muscle cells

    The Board of Regents of the University of Texas System · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 9029318

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 9028499

    Bone cutting device

    The Regents of the University of California · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 9029521

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 9028842

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Northwestern University · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 9029338

    Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 9028809

    Compositions, methods and uses for expression of enterobacterium-associated peptides

    Takeda Vaccines, Inc. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 9028877

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 9029342

    Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 9029502

    Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 9029388

    Condensed heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 9029326

    Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides

    China Medical University · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 9029344

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 9029509

    Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)

    The Regents of the University of California · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 9029413

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 9029536

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 9028841

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Health, Inc. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 9029550

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 9029530

    Detection of oligosaccharides

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 9029525

    Compositions and methods for inhibiting expression of GSK-3 genes

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 9029557

    Labeled A4B2 ligands and methods therefor

    The Regents of the University of California · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 9029546

    Pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 9029394

    2-phenyl-4-quinolones as anticancer agents

    China Medical University · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 9029321

    Methods and compositions for targeting adipose cells in mammals

    The Board of Regents of the University of Texas · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 9028887

    Method improve spatial memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 9028819

    Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. EP 2870969

    Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse

    BIOCODEX [FR] · Granted Wed May 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 9034311

    Pyridin-2(1 H)-one derivatives as JAK inhibitors

    Almirall, S.A. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 9034313

    Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

    Inovio Pharmaceuticals, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 9034829

    pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

    Northwestern University · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 9034343

    Attenuated human parainfluenza virus, methods and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 9034336

    Immunomodulators and immunomodulator conjugates

    Regents of the University of Minnesota · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 9034323

    Method for control of post-prandial glucose

    HALOZYME, INC. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 9034347

    Drug delivery system and method for the treatment of neuro-degenerative disease

    Arphios Corporation · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 9034642

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 9034881

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 9034903

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 9034923

    Methods for the treatment of senile dementia of the alzheimer's type

    Phenomenome Discoveries Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 9035041

    Process for triphosphate oligonucleotide synthesis

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2035?

1,447 published patents in our USPTO index have expiration dates falling in calendar year 2035.